BioSpace News Archive

Business

Cigna’s Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent – One Year Ahead of Goal

Milestone achieved through a collaborative approach, focused on safer prescribing and expanded case management support.

March 28, 2018
·
8 min read
Business

Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration

Collaboration plans to establish Biocept as Thermo Fisher Center of Excellence for liquid biopsy and to pursue commercial opportunities in both pharmaceutical and clinical markets.

March 28, 2018
·
4 min read
Business

Synthego Appoints CRISPR Pioneer Dr. Jennifer Doudna to Advisory Board to Accelerate Company’s Genome Engineering Mission

Doudna to advise Synthego as the company develops technology and services to further the adoption of CRISPR, bringing access, precision and automation to genome engineering

March 28, 2018
·
3 min read
Business

Update March 28, 2018: Lattice Biologics Ltd. Management Cease Trade Order

Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) is providing this default status report in accordance with National Policy 12-203 – Management Cease Trade Orders.

March 28, 2018
·
2 min read
Business

Nanospectra Biosciences Provides Corporate Update

Company Completes Critical Steps Towards Commercialization of AuroLase Therapy for Solid Tumor Ablation for Localized Prostate Cancer

March 28, 2018
·
4 min read
Business

PPD Expands GMP Biologics Testing Capacity

Substantially Increases Ability to Support Large Molecule Development

March 28, 2018
·
3 min read
Business

AstraZeneca Tops the Pharmaceutical Innovation Index for the First Time

- A significant resurgence from Big Pharma in the top 10 The eighth annual Pharmaceutical Innovation Index, released by IDEA Pharma today, sees AstraZeneca top the industry for the first time.

March 28, 2018
·
3 min read
Policy

Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs

Products marketed as dietary supplements contained undisclosed active pharmaceutical ingredients

March 28, 2018
·
3 min read
Drug Development

Wize Pharma Enrolls First Patient in Phase IV Study of LO2A for Symptomatic Treatment of Dry Eye Syndrome in Patients With Sjögren’s Syndrome

Wize Pharma, Inc. announced it has enrolled the first patient in its Phase IV clinical trial in Israel for LO2A in the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren’s syndrome.

March 28, 2018
·
3 min read
Bio NC

High Point Clinical Trials Center and Amyndas Pharmaceuticals Announce the Completion of the Complement C3 Inhibitor AMY-101 First in Human Study

High Point Clinical Trials Center (HPCTC) and Amyndas Pharmaceuticals jointly announce the completion of the AMY-101 First in Human (FIH) study.

March 28, 2018
·
4 min read